Markel Group Inc. Acquires 3,250 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

by · The Markets Daily

Markel Group Inc. lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 15.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 24,064 shares of the healthcare conglomerate’s stock after purchasing an additional 3,250 shares during the period. Markel Group Inc.’s holdings in UnitedHealth Group were worth $14,070,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in UNH. Tealwood Asset Management Inc. purchased a new stake in UnitedHealth Group in the third quarter worth about $2,905,000. Asset Planning Services Inc. LA ADV boosted its stake in shares of UnitedHealth Group by 1.2% during the 3rd quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate’s stock worth $7,288,000 after acquiring an additional 150 shares during the last quarter. Sequoia Financial Advisors LLC increased its holdings in UnitedHealth Group by 13.7% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock worth $14,603,000 after acquiring an additional 3,006 shares in the last quarter. Americana Partners LLC increased its stake in UnitedHealth Group by 10.8% in the 3rd quarter. Americana Partners LLC now owns 20,377 shares of the healthcare conglomerate’s stock worth $11,914,000 after buying an additional 1,984 shares in the last quarter. Finally, Hennion & Walsh Asset Management Inc. lifted its holdings in UnitedHealth Group by 14.8% in the 2nd quarter. Hennion & Walsh Asset Management Inc. now owns 9,960 shares of the healthcare conglomerate’s stock worth $5,072,000 after purchasing an additional 1,283 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on UNH shares. Morgan Stanley cut their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Cantor Fitzgerald increased their price target on UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and increased their target price for the stock from $481.00 to $647.00 in a research note on Wednesday, July 17th. UBS Group reduced their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Finally, Truist Financial restated a “buy” rating and issued a $625.00 target price (down from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $615.53.

Read Our Latest Research Report on UNH

UnitedHealth Group Stock Up 1.8 %

Shares of NYSE UNH opened at $616.33 on Friday. The firm has a 50-day moving average price of $581.93 and a 200 day moving average price of $545.03. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $619.80. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $567.20 billion, a price-to-earnings ratio of 40.15, a price-to-earnings-growth ratio of 1.75 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same quarter in the previous year, the company posted $6.56 EPS. The business’s revenue was up 9.2% on a year-over-year basis. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.36%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading